This web page is currently being updated. Meanwhile, Targeted updates (TUs) were designed as a fast but methodologically sound method to produce up-to-date evidence for policy makers based on Cochrane reviews. Cochrane Skin got involved in the pilot project and created the TUs below. Further detail can be found here. |  |
- Oral propranolol for infantile haemangioma in infants and children.
- Topical timolol (beta blocker) for infantile haemangioma in infants and children.
- Interventions for cutaneous sporotrichosis.
Supplementary information can be obtained by emailing Nuala Livingstone.